CTC

CTC is a specialized, full-service CRO with a unique, integrated model combining traditional CRO services with an owned and operated site network. This provides sponsors with a streamlined, cost-effective solution for early-phase trials, particularly in oncology and cell therapy, with a strong emphasis on First-in-Human studies. The company leverages its deep in-house medical and operational expertise, a high-capacity clinic infrastructure, and a flexible approach to manage complex and decentralized trials. With over 140 employees and a track record of 500+ trials, CTC is positioned as a key partner for biotech and pharma companies navigating the critical early stages of clinical development.

Integrated full-service CRO with an owned and operated network of 7 clinical research clinics, specializing in First-in-Human and early-phase trials. The platform combines project management, medical, and operational services with dedicated physical site infrastructure, enabling streamlined, cost-effective trial execution.

CTC competes with large, global full-service CROs (e.g., IQVIA, PPD) and niche, regional early-phase specialists. Its key differentiator is the ownership of its site network, which few CROs replicate. This allows for greater control, faster startup, and potentially lower costs compared to the traditional CRO model that relies on contracting with independent sites. Its main competitors are other specialized early-phase CROs with strong site relationships in Europe.